Does BridgeBio Pharma Inc. (NASDAQ:BBIO) have deteriorating prospects?
BridgeBio Pharma Inc. (NASDAQ:BBIO) shares traded 1.50% higher at $32.52 on Wall Street last session. In accordance with the data, 11 analysts cover BridgeBio Pharma Inc. (NASDAQ:BBIO). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $50.00 and a low of $30.00, […]
BridgeBio Pharma Inc. (NASDAQ:BBIO): A Fundamentally Weighted Stock for Long-Term Investors
The stock of BridgeBio Pharma Inc. (NASDAQ:BBIO) last traded at $17.36, up 2.78% from the previous session. Data from the available sources indicates that BridgeBio Pharma Inc. (NASDAQ:BBIO) is covered by 11 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]